Iberdomide vs. Observation Post Ide-Cel CAR-T

Randomized Phase 2 Study of Iberdomide Maintenance Therapy Following Idecabtagene Vicleucel CAR-T in Multiple Myeloma Patients

  • Myeloma Service

Sorting 41 by

Memorial Sloan Kettering Cancer Center
New York, NY
  • Accepting patients
  • Show Principal Investigator
Medical Oncology and Hematology Associates-West Des Moines
Clive, IA
(515) 241-3305
  • Accepting patients
  • Show Principal Investigator
MercyOne Des Moines Medical Center
Des Moines, IA
(515) 358-6613
  • Accepting patients
Cedars-Sinai Medical Center - UCLA School of Medicine
Samuel Oschin Comprehensive Cancer Institute
Los Angeles, CA
  • Accepting patients
  • Show Principal Investigator
Nebraska Medicine (Bellevue Medical Center)
Bellevue, NE
  • Accepting patients
  • Show Principal Investigator
Nebraska Medicine (Village Pointe)
Omaha, NE
  • Accepting patients
  • Show Principal Investigator
University of Nebraska Medical Center
Fred & Pamela Buffett Cancer Center
Omaha, NE
  • Accepting patients
  • Show Principal Investigator
Swedish - First Hill Campus
Seattle, WA
  • Accepting patients
Swedish Cancer Institute
Swedish Edmonds Campus
Edmonds, WA
  • Accepting patients
123 hidden based on your filters. Show All

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print Report

Print a patient-friendly report to share with your patient.

(888) 828-2206

We can help answer any questions and connect you (or your patient) with the study team.

Schedule Call

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.